About: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.01 (+5.24%)
CNTBNASDAQConnect Biopharma Holdings Ltd
Loading watchlist status…
Connect Biopharma Holdings Ltd share price
CNTB price activity
Last Price
$2.010
Change (24hr)
0.10 USD (5.24%)
Volume
944.37K
Volume (4w avg)
-
Open
$1.91
Day Range
$1.89 - $2.10
Previous Close
$1.91
Last Trade
09 Sep, 8:21 pm GMT+0
Delayed
09 Sep, 8:21 pm GMT+0
CNTB price performance
-14.83%
5D
-8.84%
1M
-28.72%
YTD
14.2%
1Y
Delayed
09 Sep, 8:21 pm GMT+0
CNTB Market Signals